id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-0297-0021,FDA,FDA-2014-N-0297,Cited Materials re Comment from David Schmidt,Supporting & Related Material,Background Material,2014-09-19T04:00:00Z,2014,9,,,2016-03-22T18:28:28Z,,0,0,09000064817eb198
FDA-2014-N-0297-0006,FDA,FDA-2014-N-0297,Letter from FDA CDRH to AdvaMed,Other,Letter(s),2014-07-14T04:00:00Z,2014,7,2014-07-14T04:00:00Z,,2014-07-14T17:23:35Z,,0,0,09000064817ab53f
FDA-2014-N-0297-0001,FDA,FDA-2014-N-0297,"Reclassification of Surgical Mesh for Transvaginal Pelvic Organ Prolapse
Repair and Surgical Instrumentation for Urogynecologic Surgical Mesh
Procedures; Designation of Special Controls for Urogynecologic Surgical
Mesh Instrumentation",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2014-05-01T04:00:00Z,2014,5,2014-05-01T04:00:00Z,2014-07-31T03:59:59Z,2014-08-01T01:03:51Z,2014-09907,0,0,09000064816da464